289 related articles for article (PubMed ID: 20957845)
1. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
Schwartz JR; Khan A; McCall WV; Weintraub J; Tiller J
J Clin Sleep Med; 2010 Oct; 6(5):450-7. PubMed ID: 20957845
[TBL] [Abstract][Full Text] [Related]
2. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
Black JE; Hull SG; Tiller J; Yang R; Harsh JR
J Clin Sleep Med; 2010 Oct; 6(5):458-66. PubMed ID: 20957846
[TBL] [Abstract][Full Text] [Related]
3. Armodafinil.
Garnock-Jones KP; Dhillon S; Scott LJ
CNS Drugs; 2009 Sep; 23(9):793-803. PubMed ID: 19689169
[TBL] [Abstract][Full Text] [Related]
4. Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.
Czeisler CA; Walsh JK; Wesnes KA; Arora S; Roth T
Mayo Clin Proc; 2009 Nov; 84(11):958-72. PubMed ID: 19880686
[TBL] [Abstract][Full Text] [Related]
5. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
[TBL] [Abstract][Full Text] [Related]
6. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
7. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
Roth T; Rippon GA; Arora S
Sleep Breath; 2008 Mar; 12(1):53-62. PubMed ID: 17874255
[TBL] [Abstract][Full Text] [Related]
8. Armodafinil for excessive daytime sleepiness.
Nishino S; Okuro M
Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
[TBL] [Abstract][Full Text] [Related]
10. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W
Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
[TBL] [Abstract][Full Text] [Related]
12. Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension.
Menn SJ; Yang R; Lankford A
J Clin Sleep Med; 2014 Nov; 10(11):1181-91. PubMed ID: 25325609
[TBL] [Abstract][Full Text] [Related]
13. Armodafinil: a new treatment for excessive sleepiness.
Lankford DA
Expert Opin Investig Drugs; 2008 Apr; 17(4):565-73. PubMed ID: 18363520
[TBL] [Abstract][Full Text] [Related]
14. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.
Hirshkowitz M; Black J
CNS Drugs; 2007; 21(5):407-16. PubMed ID: 17447828
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of armodafinil: effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder.
Erman MK; Seiden DJ; Yang R; Dammerman R
J Occup Environ Med; 2011 Dec; 53(12):1460-5. PubMed ID: 22104981
[TBL] [Abstract][Full Text] [Related]
16. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.
Keating GM; Raffin MJ
CNS Drugs; 2005; 19(9):785-803. PubMed ID: 16142993
[TBL] [Abstract][Full Text] [Related]
17. Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.
Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P
Drugs Aging; 2011 Feb; 28(2):139-50. PubMed ID: 21275439
[TBL] [Abstract][Full Text] [Related]
18. Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study.
Greve DN; Duntley SP; Larson-Prior L; Krystal AD; Diaz MT; Drummond SP; Thein SG; Kushida CA; Yang R; Thomas RJ
J Clin Sleep Med; 2014 Feb; 10(2):143-53. PubMed ID: 24532997
[TBL] [Abstract][Full Text] [Related]
19. Armodafinil in the treatment of excessive sleepiness.
Bogan RK
Expert Opin Pharmacother; 2010 Apr; 11(6):993-1002. PubMed ID: 20307223
[TBL] [Abstract][Full Text] [Related]
20. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
Kuan YC; Wu D; Huang KW; Chi NF; Hu CJ; Chung CC; Tam KW; Huang YH
Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
